Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 1998

View Archived Issues

PAF antagonists in the treatment of asthma: promise or hype?

Onconase and proteasome inhibitors have synergistic antitumor activity, even in resistant tumors

Ligand files new drug submission for Panretin Gel in Canada

Coulter initiates expanded access program for Bexxar

HER2 diagnostic test approved in U.S.; will help identify candidates for Herceptin therapy

Targeted Genetics initiates phase II trials for proprietary gene therapy compound

Orphan Medical's Busulfex Injection granted priority review

Yoshitomi: Annual Report 1998

New orally active antitumor platinum complexes synthesized at SS Pharm.

Gruenenthal develops new opioid analgesics

Akzo describes selective 5-HT2C agonists for depression and other CNS disorders

Dual TxA2 antagonists and NO donors and their use disclosed by ADIR

New series of beta-agonists in early development at Yamanouchi

Use of rPAF-AH in necrotizing colitis, ARDS and acute pancreatitis

Elan completes acquisition of NanoSystems

ThromboSol effectively preserves platelet function and cell recovery in in vivo study

Radiolabeled peptide from Diatide effectively pinpoints site of infection

Long-term ETA receptor blockade shows detrimental effects on LV remodeling

Genotyping accurately predicts response to treatment with 5-LO inhibitor

ZK-137316: chronic, low-dose regimen prevents pregnancy in monkeys with little cycle disruption

Anti-IgE antibody in the treatment of asthma: an interesting theory is validated

Lilly to pursue new indication for Zyprexa despite FDA nonapprovable letter

Novel antiepileptic agent developed by SK enters clinical trials

Actonel now available for treatment of Paget's disease

Pivotal trial of exisulind for prostate cancer recurrence fully enrolled

InKine colonic purgative proceeds to phase III trials

Cytogen anticipates selection of new marketing partner for Quadramet

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...